Rocket


News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership


All
13F
13D/G
Other

BAYER AKTIENGESELLSCHAFT (BAYRY) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/24/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
02/13/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
02/11/2022 SC 13G BAYER AKTIENGESELLSCHAFT reports a 23.2% stake in Century Therapeutics, Inc.
10/15/2021 4 Bayer World Investments B.V. (Former 10% Owner) has filed a Form 4 on Pyxis Oncology, Inc.
Txns: Converted 2,742,338 shares @ $0
Converted 11,362,462 convertible preferred @ $0
Converted 6,076,072 convertible preferred @ $0
10/07/2021 3 Bayer World Investments B.V. (10% Owner) has filed a Form 3 on Pyxis Oncology, Inc.
06/23/2021 4 BAYER AKTIENGESELLSCHAFT (10% Owner) has filed a Form 4 on Century Therapeutics, Inc.
Txns: Converted 10,390,600 shares @ $0
Converted 1,535,238 shares @ $0
Bought 750,000 shares @ $20, valued at $15M
Converted 26,143,790 preferred shares @ $0
Converted 3,862,813 preferred shares @ $0
06/17/2021 3 BAYER AKTIENGESELLSCHAFT (10% Owner) has filed a Form 3 on Century Therapeutics, Inc.
12/03/2020 4 BAYER AKTIENGESELLSCHAFT (10% Owner) has filed a Form 4 on Elanco Animal Health Inc
Txns: Sold 54,500,000 shares @ $29.8416, valued at $1626.4M
12/03/2020 SC 13G/A BAYER AKTIENGESELLSCHAFT reports a 3.9% stake in Elanco Animal Health Incorporated
08/03/2020 3 BAYER AKTIENGESELLSCHAFT (10% Owner) has filed a Form 3 on Elanco Animal Health Inc
08/03/2020 SC 13G BAYER AKTIENGESELLSCHAFT reports a 15.5% stake in Elanco Animal Health Incorporated
01/30/2018 4 BAYER AKTIENGESELLSCHAFT (10% Owner) has filed a Form 4 on CRISPR Therapeutics AG
Txns: Bought 527,472 shares @ $22.75, valued at $12M
11/25/2016 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
11/16/2016 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
11/15/2016 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
11/10/2016 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
11/09/2016 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
10/31/2016 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
10/28/2016 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
10/18/2016 3 Bayer Global Investments B.V. (10% Owner) has filed a Form 3 on CRISPR Therapeutics AG
10/17/2016 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
10/13/2016 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
10/12/2016 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
10/11/2016 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
09/21/2016 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
09/20/2016 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
09/16/2016 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
09/14/2016 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
09/06/2016 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
07/27/2016 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party
07/14/2016 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party
07/05/2016 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party
06/28/2016 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy